Follow
Simon Anderson
Simon Anderson
Unknown affiliation
Verified email at bangor.ac.uk
Title
Cited by
Cited by
Year
Magnetic functionalized nanoparticles for biomedical, drug delivery and imaging applications
SD Anderson, VV Gwenin, CD Gwenin
Nanoscale research letters 14 (1), 1-16, 2019
2202019
Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase
P Ball, E Thompson, S Anderson, V Gwenin, C Gwenin
European Journal of Pharmaceutical Sciences 127, 217-224, 2019
132019
Cell-Penetrating Peptides as a Tool for the Cellular Uptake of a Genetically Modified Nitroreductase for use in Directed Enzyme Prodrug Therapy
SD Anderson, RJ Hobbs, VV Gwenin, P Ball, LA Bennie, JA Coulter, ...
Journal of Functional Biomaterials 10 (4), 45, 2019
72019
Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle‐directed enzyme prodrug therapy as a novel approach to cancer …
P Ball, J Halliwell, S Anderson, V Gwenin, C Gwenin
MicrobiologyOpen, e1110, 2020
42020
The YfkO Nitroreductase from Bacillus Licheniformis on Gold-Coated Superparamagnetic Nanoparticles: Towards a Novel Directed Enzyme Prodrug Therapy Approach
P Ball, R Hobbs, S Anderson, E Thompson, V Gwenin, C Von Ruhland, ...
Pharmaceutics 13 (4), 517, 2021
22021
Harnessing a biocatalyst to bioremediate the purification of alkylglycosides
SC Alice J. C. Wahart, Jonathan P. Dolan, Simon D. Anderson, Aisling Ní ...
ChemBioChem, 2023
2023
The Dinitrobenzamide Mustard Prodrugs, PR-104A and SN27686, for Use in a Novel MNDEPT Cancer Prodrug Therapy Approach
P Ball, E Thompson, S Anderson, V Gwenin, A Ashoorzadeh, J Smaill, ...
Bioscience Reports, 2023
2023
The application of CPPs to improve the cellular uptake of a novel delivery vector for use in directed enzyme prodrug therapy
S Anderson
Bangor University, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–8